Fulvio Borella

ORCID: 0000-0001-8398-7557 · 5 papers in corpus
2025
The oncologist ·doi:10.1093/oncolo/oyae325

Ovarian clear cell carcinoma (OCCC) accounts for ~10% of all epithelial ovarian cancers and is considered a different entity from the more common high-grade serous ovarian carcinoma (HGSC), with distinct clinical presentations, different ri…

2025
Current issues in molecular biology ·doi:10.3390/cimb47090726

Clear cell ovarian carcinoma is a rare and aggressive histologic subtype of epithelial ovarian cancer, characterized by a chemoresistant phenotype and distinct immunogenomic features. Despite early-phase trials showing a limited response to…

2023
Journal of clinical medicine ·doi:10.3390/jcm12124032

Background: The proportion of frozen embryo transfer cycles has consistently grown in recent decades. Some adverse obstetric outcomes after frozen embryo transfer could possibly be explained by different approaches in endometrial preparatio…

2021
ACS infectious diseases ·doi:10.1021/acsinfecdis.0c00839

Over the past 20 years, important relationships between the microbiota and human health have emerged. A link between alterations of microbiota composition (dysbiosis) and cancer development has been recently demonstrated. In particular, the…

other 2020
Journal of clinical medicine ·doi:10.3390/jcm9124076

BACKGROUND: The assessment of ovarian reserve in the case of endometrioma is of pivotal importance for planning a tailored management. However, both the antral follicle count (AFC) and the antimüllerian hormone (AMH) dosage are subject to a…